Attached files

file filename
10-Q - 10-Q - CytoDyn Inc.d241969d10q.htm
EX-32.1 - EX-32.1 - CytoDyn Inc.d241969dex321.htm
EX-31.2 - EX-31.2 - CytoDyn Inc.d241969dex312.htm
EX-31.1 - EX-31.1 - CytoDyn Inc.d241969dex311.htm
EX-10.1 - EX-10.1 - CytoDyn Inc.d241969dex101.htm

Exhibit 32.2

Certification of Chief Financial Officer


In connection with the Quarterly Report of CytoDyn Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended August 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Michael D. Mulholland, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 12, 2016

/s/ Michael D. Mulholland

Michael D. Mulholland

Chief Financial Officer